Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, Germany, Japan, Singapore, China, South Korea, Netherlands, Israel
Industries Focus
- Technology
- Healthcare
- Real Estate
- Telecommunications
- Software
- Semiconductors
- Media and Entertainment
Investment Size:
1,000,000 to 6,000,000 USD
Investor Details Founded: 1993
Established in 1993, Yozma Group is a pioneering venture capital firm that played a pivotal role in creating and developing Israel's venture capital industry. The firm specializes in making equity investments in high-growth technology companies across sectors where Israel has demonstrated world leadership, including Communications, Information Technologies, and Life Sciences. Yozma Group has successfully established multiple funds, each capitalized with over $20 million, which have become the backbone of the Israeli venture market.
Yozma Group's investment strategy focuses on early-stage companies, providing them with the necessary capital and strategic support to scale and succeed. The firm has developed close working relationships with leading academic institutions in Israel, facilitating access to a proprietary deal flow and fostering innovation. Additionally, Yozma Group maintains strong connections with top-tier international venture funds, enhancing its ability to support portfolio companies in establishing a global presence.
Over the years, Yozma Group has been instrumental in the growth of numerous Israeli startups, many of which have achieved significant milestones such as mergers and acquisitions, global IPOs, and successful exits. The firm's seasoned management team, with decades of collective experience, is committed to nurturing the growth of innovative startups and contributing to the advancement of Israel's technology ecosystem.
Requirements
- High-growth technology companies
- Early-stage investments
- Sectors: Communications, Information Technologies, Life Sciences
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- CanFite BioPharma
- Illumigyn
- Syntekabio
Mentioned In
-
$24.95
-
$49.95
-
$19.95
-
$19.95
-
$24.95
Claim this Investor
Are you an official representative of Yozma Group?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim